ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
Dow Jones
39.112,16
-0,76%
Euro vs US Dollar
1,07103
0,01%
Bitcoin
61.702,17
-0,16%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Biofrontera Inc (BFRIW)

  7. Biofrontera Inc (BFRIW) News

BFRIW

Biofrontera (BFRIW)

Biofrontera Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BFRIW
DatumZeitQuelleÜberschriftSymbolFirma
24/06/202414h30GlobeNewswire Inc.Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL LampNASDAQ:BFRIWBiofrontera Inc
14/06/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
22/05/202422h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BFRIWBiofrontera Inc
22/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
15/05/202423h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
10/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BFRIWBiofrontera Inc
16/12/202214h30GlobeNewswire Inc.Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of StockholdersNASDAQ:BFRIWBiofrontera Inc
30/11/202220h08GlobeNewswire Inc.Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor ConferenceNASDAQ:BFRIWBiofrontera Inc
28/11/202217h05GlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022NASDAQ:BFRIWBiofrontera Inc
21/11/202214h48GlobeNewswire Inc.Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and TrunkNASDAQ:BFRIWBiofrontera Inc
14/11/202214h45GlobeNewswire Inc.Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIWBiofrontera Inc
10/11/202217h52GlobeNewswire Inc.Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022NASDAQ:BFRIWBiofrontera Inc
08/11/202222h45GlobeNewswire Inc.Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AGNASDAQ:BFRIWBiofrontera Inc
31/10/202213h55GlobeNewswire Inc.Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AGNASDAQ:BFRIWBiofrontera Inc
24/10/202213h45GlobeNewswire Inc.Biofrontera Inc. Names Fred Leffler as Chief Financial OfficerNASDAQ:BFRIWBiofrontera Inc
20/10/202217h40GlobeNewswire Inc.Biofrontera Inc. to Present at the LD Micro Main Event XV Investor ConferenceNASDAQ:BFRIWBiofrontera Inc
18/10/202216h30GlobeNewswire Inc.Biofrontera Inc. to Sponsor the 2022 Fall Clinical Dermatology ConferenceNASDAQ:BFRIWBiofrontera Inc
14/10/202214h40GlobeNewswire Inc.Biofrontera Inc. Adopts Limited Duration Shareholder Rights PlanNASDAQ:BFRIWBiofrontera Inc
12/10/202220h00GlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022NASDAQ:BFRIWBiofrontera Inc
05/10/202223h00GlobeNewswire Inc.Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022NASDAQ:BFRIWBiofrontera Inc
29/09/202216h04GlobeNewswire Inc.Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities ConferenceNASDAQ:BFRIWBiofrontera Inc
26/09/202214h30GlobeNewswire Inc.Biofrontera Inc.’s Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer AwardsNASDAQ:BFRIWBiofrontera Inc
13/09/202214h30GlobeNewswire Inc.Biofrontera Inc. Names Gerard DiGirolamo as National Sales DirectorNASDAQ:BFRIWBiofrontera Inc
06/09/202216h31GlobeNewswire Inc.Biofrontera Inc. Announces Notice of Allowance for Nanoemulsion Composition-of-Matter U.S. PatentNASDAQ:BFRIWBiofrontera Inc
18/08/202217h04GlobeNewswire Inc.Biofrontera Inc.’s Leslie Hopkins Named PM360 Trailblazer 2022 Brand Champion for DermatologyNASDAQ:BFRIWBiofrontera Inc
12/08/202214h33GlobeNewswire Inc.Biofrontera Inc. Reports Second Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIWBiofrontera Inc
04/08/202214h30GlobeNewswire Inc.Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022NASDAQ:BFRIWBiofrontera Inc
01/08/202217h00GlobeNewswire Inc.Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbHNASDAQ:BFRIWBiofrontera Inc
27/07/202214h45GlobeNewswire Inc.Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private PlacementNASDAQ:BFRIWBiofrontera Inc
12/07/202214h00GlobeNewswire Inc.Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022NASDAQ:BFRIWBiofrontera Inc
 Showing the most relevant articles for your search:NASDAQ:BFRIW

Kürzlich von Ihnen besucht

TG
A3K3DA
Iberdrola
BIT
NSCIT4392279
IBRD
TSXV
CUO
Copper One
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten